Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6068-6073

  Waheed, Ishrat ^a   Guo, Z Sheng ^a   Chen, G Aaron ^a   Weiser, Todd S ^a   Nguyen, Dao M ^a   Schrump, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; DNA SEQUENCE; HUMAN; HUMAN CELL; NUCLEIC ACID PROBE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SIMIAN VIRUS 40;

ADENOVIRIDAE; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL DIVISION; GENE TRANSFER TECHNIQUES; GENES, IMMEDIATE-EARLY; GENES, VIRAL; GENETIC VECTORS; HUMANS; MESOTHELIOMA; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS; PHENOTYPE; PLEURAL NEOPLASMS; SIMIAN VIRUS 40; TUMOR CELLS, CULTURED;

EID: 0033572314     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lechner, J. F., Tesfaigzi, J., and Gerwin, B. I. Oncogenes and tumor-suppressor genes in mesothelioma-a synopsis. Environ. Health Perspect., 105S: 1061-1067, 1997.
2. Lee, W-C., and Testa, J. R. Somatic genetic alterations in human malignant mesothelioma. Int. J. Oncol., 14: 181-188, 1999.
3. Ramael, M., Segers, K., and Van Marck, E. Differential immunohistochemical staining for retinoblastoma protein with the antibodies C15 and 1F8 in malignant mesothelioma. Pathol. Res. Pract., 190: 138-141, 1994.
4. INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J. Natl. Cancer Inst., 87: 1870-1875, 1995.
5. Van der Meeren, A., Seddon, M. B., Kispert, J., Harris, C. C., and Gerwin, B. I. Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma. Eur. Respir. Rev., 3: 177-179, 1993.
6. Cheng, J. Q., Jhanwar, S. C., Lubeck, M., and Testa, J. R. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res., 53: 4761-4763, 1993.
7. Xiao, S., Li, D., Vijg, J., Sugarbaker, D. J., Corson, J. M., and Fletcher, J. A. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res., 55: 2968-2971, 1995.
8. Chin, L., Pomerantz, J., and Depinho, R. A. The INK4a/ARF tumor suppressor: one gene-two products-two pathways. Trends Biochem. Sci., 23: 291-296, 1998.
9. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12: 2984-2991, 1998.
10. Carbone, M., Fisher, S., Powers, A., Pass, H. I., and Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J. Cell Physiol., 180: 167-172, 1999.
11. Butel, J. S., and Lednicky, J. A. Cell and molecular biology of simian virus 40. Implications for human infections and disease. J. Natl. Cancer Inst., 91: 119-134, 1999.
12. Quartin, R. S., Cole, C. N., Pipas, J. M., and Levine, A. J. The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J. Virol., 68: 1334-1341, 1994.
13. Conzen, S. D., Snay, C. A., and Cole, C. N. Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen. J. Virol., 71: 4536-4543, 1997.
14. Levresse, V., Moritz, S., Renier, A., Kheuang, L., Galateau-Salle, F., Mege, J. P., Piedbois, P., Salmons, B., Guenzburg, W., and Jaurand, M. C. Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents. Oncogene, 16: 1041-1053, 1998.
15. Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I-W., Karnezis, A. N., Zon, L., Kyriakis, J., Rundell, K., and Pestell, R. G. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA, 93: 12861-12866, 1996.
16. Cicala, C., Pompetti, F., and Carbone, M. SV40 induces mesotheliomas in hamsters. Am. J. Pathol., 142: 1524-1533, 1993.
17. Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M. R., Di Muzio, M., Mew, D. J. Y., Levine, A. S., and Procopio, A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene, 9: 1781-1790, 1994.
18. Testa, J. R., Carbone, M., Hirvonen, A., Khalili, K., Krynska, B., Linnainmaa, K., Pooley, F. D., Rizzo, P., Rusch, V., and Xiao, G-H. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res., 58: 4505-4509, 1998.
19. Carbone, M., Rizzo, P., Grimley, P. M., Procopio, A., Mew, D. J. Y., Shridhar, V., de Bartolomeis, A., Esposito, V., Giuliano, M. T., Steinberg, S. M., Levine, A. S., Giordano, A., and Pass, H. I. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med., 3: 908-912, 1997.
20. DeLuca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., Carbone, M., and Giordano, A. The retinoblastoma gene family pRb/p105m o196m pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat. Med., 3: 913-916, 1997.
21. Zhang, Y., Xiong, Y., and Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the RB and p53 tumor suppression pathways. Cell, 92: 725-734, 1998.
22. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
23. Guo, Z. S., Wang, L. H., Eisensmith, R. C., and Woo, S. L. C. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther., 3: 802-810, 1996.
24. Belt, A. J., Haddara, W., Prevec, L., and Graham, F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA, 91: 8802-8806, 1994.
25. INK4. Cancer Gene Ther., 3: 357-364, 1996.
26. Girardi, A. J., Sweet, B. H., Slotnick, V. B., and Hilleman, M. R. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV40 (27298). Proc. Soc. Exp. Biol. Med., 109: 649-660, 1962.
27. Galateau-Salle, F., Bidet, P., Iwatsubo, Y., Gennetay, E., Renier, A., Letourneux, M., Pairon, J, C., Moritz, S., Brochard, P., Jaurand, M. C., and Freymuth, F. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J. Pathol., 184: 252-257, 1998.
28. Strickler, H. D., Rosenberg, P. S., Devesa, S. S., Hertel, J., Fraumeni, J. F., Jr., and Goedert, J. J. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. J. Am. Med. Assoc., 279: 292-295, 1998.
29. Chen, H., Campisi, J., and Padmanabhan, R. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J. Biol. Chem., 271: 13959-13967, 1996.
30. Porras, A., Bennett, J., Howe, A., Tokos, K., Bouck, N., Henglein, B., Sathyamangalam, S., Thimmapaya, B., and Rundell, K. A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J. Virol., 70: 6902-6908, 1996.
31. Raptis, L., Brownell, H. L., Corbley, M. J., Wood, K. W., Wang, D., and Haliotis, T. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40. Cell Growth Differ, 8: 891-901, 1997.
32. Metcalf, R. A., Welsh, J. A., Bennett, W. P., Seddon, M. B., Lehman, T. A., Pelin, K., Linnainmaa, K., Tammilehto, L., Mattson, K., Gerwin, B. I., and Harris, C. C. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res., 52: 2610-2615, 1992.
33. Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz, O., Brok-Simoni, F., Rechavi, G., and Reichert, N. Absence of p53 mutations in malignant mesotheliomas. Am. J. Respir. Cell Mol. Biol., 16: 9-13, 1997.
34. Carbone, M., Rizzo, P., and Pass, H. I. Simian virus 40, poliovaccines and human tumors; a review of recent developments. Oncogene, 15: 1877-1888, 1997.
35. Price, T. N., Moorwood, K., James, M. R., Burke, J. F., and Mayne, L. V. Cell cycle progression, morphology and contact inhibition are regulated by the amount of SV40 T antigen in immortal human cells. Oncogene, 9: 2897-2904, 1994.
36. Gonos, E. S., Burns, J. S., Mazars, G. R., Kobma, A., Riley, T. E. W., Barnett, S. C., Zafarana, G., Ludwig, R. L., Ikram, Z., Powell, A. J., and Jat, P. S. Rat embryo fibroblasts immortalized with simian virus 40 large T antigen undergo senescence upon its inactivation. Mol. Cell. Biol., 16: 5127-5138, 1996.
37. Flanagan, W. M., Wagner, R. W., Grant, D., Lin, K-Y., and Matteucci, M. D. Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide. Nat. Biotechnol., 17: 48-52, 1999.
38. 1 control. Cancer Res., 55: 4818-4823, 1995.
39. Ludlow, J. W., DeCaprio, J. A., Huang, C. M., Lee, W. H., Paucha, E., and Livingston, D. M. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell, 56: 57-65, 1989.
40. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., and Sherr, C. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA, 95: 8292-8297, 1998.
41. Ding, H-F., and Fisher, D. E. Mechanisms of p53-mediated apoptosis. Oncogene, 9: 83-98, 1998.
42. Porras, A., Gaillard, S., and Rundell, K. The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts. J. Virol., 73: 3102-3107, 1999.